Obstetrics & Gynaecology · Pelvic Inflammatory Disease and Genital Tuberculosis

A 26-year-old woman is diagnosed with mild PID (no tubo-ovarian abscess) in an outpatient setting. According to CDC 2021 STI treatment guidelines, which outpatient regimen is recommended?

  • A Ceftriaxone 500 mg IM single dose plus doxycycline 100 mg orally twice daily for 14 days, with or without metronidazole 500 mg twice daily for 14 days
  • B Azithromycin 1 g orally stat plus doxycycline 100 mg for 7 days
  • C Ciprofloxacin 500 mg twice daily plus metronidazole 400 mg twice daily for 7 days
  • D Ofloxacin 400 mg twice daily alone for 14 days
Correct answer: A. Ceftriaxone 500 mg IM single dose plus doxycycline 100 mg orally twice daily for 14 days, with or without metronidazole 500 mg twice daily for 14 days

Explanation

CDC 2021 recommends ceftriaxone 500 mg IM as a single dose (increased from 250 mg to cover cephalosporin-resistant gonococcus) plus oral doxycycline 100 mg twice daily for 14 days, with metronidazole 500 mg twice daily for 14 days added to cover anaerobes and bacterial vaginosis-associated organisms. Azithromycin monotherapy is insufficient for PID. Fluoroquinolones (ofloxacin, ciprofloxacin) are no longer recommended by CDC for gonorrhoea-associated PID due to widespread resistance.

Reference: Shaw's Textbook of Gynaecology, 17th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Pelvic Inflammatory Disease and Genital Tuberculosis MCQs

See all Pelvic Inflammatory Disease and Genital Tuberculosis MCQs →